RESHAPE LIFESCIENCES INC (RSLS)
US76090R2004 - Common Stock
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update
Revenue Increased 16.6% in the Third Quarter of 2024 Over the Second Quarter, Representing the Third Sequential Quarter of Growth, and 6.4% Compared to the...
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
Conference Call to be Held at 4:30 pm ET on Thursday, November 14, 2024
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
Conference Call to be Held at 4:30 pm ET on Thursday, November 14, 2024...
ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX
FLEX Technology Designed to Improve the Patient Experience
ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX
FLEX Technology Designed to Improve the Patient Experience...
ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California’s Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape’s Proprietary Diabetes
Approximately $241,000 Grant Will Be Utilized to Conduct Minimally Invasive Laparoscopic Surgical Electrode Implantation Techniques and Long Duration Safety and Blood Glucose Modulation Experiments for the CARSS Project
ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California’s Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape’s Proprietary Diabetes
Approximately $241,000 Grant Will Be Utilized to Conduct Minimally Invasive Laparoscopic Surgical Electrode Implantation Techniques and Long Duration...
ReShape Lifesciences Announces 1-for-58 Reverse Stock Split
Effective as of Commencement of Trading on September 23, 2024
ReShape Lifesciences Announces 1-for-58 Reverse Stock Split
Effective as of Commencement of Trading on September 23, 2024...
RSLS Stock Earnings: Reshape Lifesciences Misses Revenue for Q2 2024
RSLS stock results show that Reshape Lifesciences missed on revenue for the second quarter of 2024.
RSLS Stock Earnings: Reshape Lifesciences Misses Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Reshape Lifesciences (NASDAQ:RSLS) just reported results for the second quarter...
ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate Update
ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
Conference Call to be Held at 4:30 pm ET on Thursday, August 15, 2024
ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
Conference Call to be Held at 4:30 pm ET on Thursday, August 15, 2024...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENV, RSLS, TLRS on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GLXZ, RSLS, TLRS on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHUY, RSLS on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SOI, RSLS, TLRS on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
RSLS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ReShape Lifesciences Inc. Is Fair to Shareholders
ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
ReShape and Vyome, a Clinical Stage Specialty Pharmaceutical Company Working To Treat Immuno-Inflammatory Diseases of Unmet Need, to Combine in All-Stock...
Why Is Cue Health (HLTH) Stock Down 40% Today?
Cue Health stock is down on Wednesday as HLTH investors react to the healthcare company filing for Chapter 7 bankruptcy relief.
Why Is Faraday Future (FFIE) Stock Down 32% Today?
Faraday Future stock is falling hard on Wednesday as FFIE investors aren't impressed by the company's earnings report for 2023.
Why Is Banzai International (BNZI) Stock Up 25% Today?
Banzai International stock is up Wednesday with heavy trading of BNZI shares after closing out a recent public offering.